{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:56:42Z","timestamp":1772819802417,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00068-024-02443-9","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T13:02:19Z","timestamp":1705669339000},"page":"567-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the safety\u00a0and efficacy\u00a0for different regimens of pharmaco-prophylaxis among severely burned patients: a randomized controlled trial"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-2043","authenticated-orcid":false,"given":"Khalid A.","family":"Al Sulaiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan","family":"Al-Ramahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohoud","family":"Aljuhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khuloud","family":"Al-Joudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz K.","family":"Alhujayri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feras","family":"Al-Shomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Silas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Al Dabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmeylan","family":"Al Harbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah","family":"AlDekhayel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Eldali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahaf","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan M.","family":"Al-Dorzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"issue":"1","key":"2443_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.burns.2018.08.006","volume":"45","author":"Q Li","year":"2019","unstructured":"Li Q, et al. Stratification of venous thromboembolism risk in burn patients by Caprini score. Burns. 2019;45(1):140\u20135.","journal-title":"Burns"},{"issue":"1","key":"2443_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/BCR.0000000000000093","volume":"36","author":"SS Satahoo","year":"2015","unstructured":"Satahoo SS, et al. Are burn patients really at risk for thrombotic events? J Burn Care Res. 2015;36(1):100\u20134.","journal-title":"J Burn Care Res"},{"issue":"2","key":"2443_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/SHK.0000000000001484","volume":"54","author":"RL Ball","year":"2020","unstructured":"Ball RL, et al. Burn-induced coagulopathies: a comprehensive review. Shock (Augusta, Ga). 2020;54(2):154.","journal-title":"Shock (Augusta, Ga.)"},{"issue":"2","key":"2443_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1076029612474840","volume":"19","author":"A Nicolaides","year":"2013","unstructured":"Nicolaides A, et al. Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence). Clin Appl Thromb Hemost. 2013;19(2):116\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"2443_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/BCR.0b013e31822dc3c7","volume":"32","author":"J Bushwitz","year":"2011","unstructured":"Bushwitz J, et al. Clinically significant venous thromboembolic complications in burn patients receiving unfractionated heparin or enoxaparin as prophylaxis. J Burn Care Res. 2011;32(6):578\u201382.","journal-title":"J Burn Care Res"},{"issue":"1","key":"2443_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/BCR.0b013e318204b2ff","volume":"32","author":"CJ Pannucci","year":"2011","unstructured":"Pannucci CJ, Osborne NH, Wahl WL. Venous thromboembolism in thermally injured patients: analysis of the National Burn Repository. J Burn Care Res. 2011;32(1):6\u201312.","journal-title":"J Burn Care Res"},{"issue":"1","key":"2443_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/jbcr\/iraa143","volume":"42","author":"A Liu","year":"2021","unstructured":"Liu A, et al. Venous thromboembolism chemoprophylaxis in burn patients: a literature review and single-institution experience. J Burn Care Res. 2021;42(1):18\u201322.","journal-title":"J Burn Care Res"},{"issue":"5","key":"2443_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/BCR.0B013E318148C887","volume":"28","author":"LD Faucher","year":"2007","unstructured":"Faucher LD, Conlon KM. Practice guidelines for deep venous thrombosis prophylaxis in burns. J Burn Care Res. 2007;28(5):661\u20133.","journal-title":"J Burn Care Res"},{"key":"2443_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2165\/00003088-200847100-00002","volume":"47","author":"B Blanchet","year":"2008","unstructured":"Blanchet B, et al. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet. 2008;47:635\u201354.","journal-title":"Clin Pharmacokinet"},{"key":"2443_CR10","doi-asserted-by":"publisher","first-page":"940","DOI":"10.6061\/clinics\/2013(07)09","volume":"68","author":"OA Aguayo-Becerra","year":"2013","unstructured":"Aguayo-Becerra OA, et al. Serum albumin level as a risk factor for mortality in burn patients. Clinics. 2013;68:940\u20135.","journal-title":"Clinics"},{"issue":"1","key":"2443_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/01.CIR.95.1.118","volume":"95","author":"B Cosmi","year":"1997","unstructured":"Cosmi B, et al. Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate. Circulation. 1997;95(1):118\u201324.","journal-title":"Circulation"},{"issue":"8","key":"2443_CR12","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.burns.2016.08.005","volume":"42","author":"RB Ahuja","year":"2016","unstructured":"Ahuja RB, et al. An analysis of deep vein thrombosis in burn patients (Part 1): comparison of D-dimer and Doppler ultrasound as screening tools. Burns. 2016;42(8):1686\u201392.","journal-title":"Burns"},{"issue":"8","key":"2443_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.burns.2016.08.007","volume":"42","author":"RB Ahuja","year":"2016","unstructured":"Ahuja RB, et al. An analysis of deep vein thrombosis in burn patients (part II): a randomized and controlled study of thrombo-prophylaxis with low molecular weight heparin. Burns. 2016;42(8):1693\u20138.","journal-title":"Burns"},{"issue":"1","key":"2443_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BCR.0b013e318204b346","volume":"32","author":"H Lin","year":"2011","unstructured":"Lin H, et al. Enoxaparin and antifactor Xa levels in acute burn patients. J Burn Care Res. 2011;32(1):1\u20135.","journal-title":"J Burn Care Res"},{"key":"2443_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc8924","volume":"14","author":"S Robinson","year":"2010","unstructured":"Robinson S, et al. Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care. 2010;14:1\u20137.","journal-title":"Crit Care"},{"issue":"6","key":"2443_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/BCR.0b013e3182a2a855","volume":"34","author":"I Faraklas","year":"2013","unstructured":"Faraklas I, et al. Evaluation of an enoxaparin dosing calculator using burn size and weight. J Burn Care Res. 2013;34(6):621\u20137.","journal-title":"J Burn Care Res"},{"issue":"1","key":"2443_CR17","first-page":"38","volume":"26","author":"M Blake","year":"2019","unstructured":"Blake M, Roadley-Battin R, Torlinski T. Prophylactic anti-coagulation after severe burn injury in critical care settings. Acta Med Litu. 2019;26(1):38.","journal-title":"Acta Med Litu"},{"issue":"10","key":"2443_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818\u201329.","journal-title":"Crit Care Med"},{"issue":"11","key":"2443_CR19","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"J-L Vincent","year":"1998","unstructured":"Vincent J-L, et al. Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med. 1998;26(11):1793\u2013800.","journal-title":"Crit Care Med"},{"issue":"3","key":"2443_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/TA.0b013e3181c453b3","volume":"68","author":"T Osler","year":"2010","unstructured":"Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the Baux score. J Trauma Acute Care Surg. 2010;68(3):690\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"2443_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8(1):202\u20134.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2443_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"JA Kellum","year":"2012","unstructured":"Kellum JA, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1\u2013138.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"2443_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0002-8703(03)00121-2","volume":"146","author":"SA Spinler","year":"2003","unstructured":"Spinler SA, et al. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J. 2003;146(1):33\u201341.","journal-title":"Am Heart J"},{"issue":"3","key":"2443_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ki.2013.152","volume":"84","author":"KE Chan","year":"2013","unstructured":"Chan KE, Thadhani RI, Maddux FW. No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. Kidney Int. 2013;84(3):555\u201361.","journal-title":"Kidney Int"},{"issue":"9","key":"2443_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/0018578717724799","volume":"52","author":"MS Green","year":"2017","unstructured":"Green MS, Tellor KB, Buckallew AR. Safety and efficacy of enoxaparin compared with unfractionated heparin for venous thromboembolism prophylaxis in hemodialysis patients. Hosp Pharm. 2017;52(9):623\u20137.","journal-title":"Hosp Pharm"},{"issue":"10","key":"2443_CR26","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.15537\/smj.2019.10.23955","volume":"40","author":"TA Althunayan","year":"2019","unstructured":"Althunayan TA, et al. Risk factors for thromboembolism in burn patients admitted to the burn unit at King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. Saudi Med J. 2019;40(10):1027.","journal-title":"Saudi Med J"},{"issue":"2","key":"2443_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.accpm.2020.03.006","volume":"39","author":"M Legrand","year":"2020","unstructured":"Legrand M, et al. Management of severe thermal burns in the acute phase in adults and children. Anaesth Crit Care Pain Med. 2020;39(2):253\u201367.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"8","key":"2443_CR28","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.bjps.2020.12.011","volume":"74","author":"P Lu","year":"2021","unstructured":"Lu P, et al. Venous thromboembolism in burns patients: are we underestimating the risk and underdosing our prophylaxis? J Plast Reconstr Aesthet Surg. 2021;74(8):1814\u201323.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"3","key":"2443_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/ebj2030006","volume":"2","author":"R Brazilek","year":"2021","unstructured":"Brazilek R, Cleland HJ. Clinical outcomes in burns patients with early venous thromboembolism prophylaxis compared with late-anticoagulated patients: a retrospective study. Eur Burn J. 2021;2(3):63\u201374.","journal-title":"Eur Burn J"},{"issue":"6","key":"2443_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.burns.2003.12.019","volume":"30","author":"AM Fecher","year":"2004","unstructured":"Fecher AM, et al. Analysis of deep vein thrombosis in burn patients. Burns. 2004;30(6):591\u20133.","journal-title":"Burns"},{"issue":"3","key":"2443_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.burns.2012.07.027","volume":"39","author":"M Hashmi","year":"2013","unstructured":"Hashmi M, Kamal R. Management of patients in a dedicated burns intensive care unit (BICU) in a developing country. Burns. 2013;39(3):493\u2013500.","journal-title":"Burns"},{"key":"2443_CR32","doi-asserted-by":"crossref","unstructured":"Geerts WH, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6 Suppl): 381s\u2013453s.","DOI":"10.1378\/chest.08-0656"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-024-02443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-024-02443-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-024-02443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T07:04:47Z","timestamp":1713769487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-024-02443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2443"],"URL":"https:\/\/doi.org\/10.1007\/s00068-024-02443-9","relation":{},"ISSN":["1863-9933","1863-9941"],"issn-type":[{"value":"1863-9933","type":"print"},{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"20 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved in April 2020 by King Abdullah International Medical Research Center Institutional Review Board, Riyadh, Saudi Arabia (ref. # RC18\/400\/R). Participants\u2019 confidentiality was strictly observed throughout the study by using an anonymous unique serial number for each subject and restricting access only to the investigators. The protection of the privacy of research participants and the level of confidentiality has been ensured. The patient or a legally authorized representative signed the consent for enrolling in the study before allocating the patient to any of the study arms. In addition, the trial was registered on ClinicalTrials.gov (identifier number: NCT05237726).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}